Please login to the form below

Not currently logged in
Email:
Password:

Pfizer's Mark Brincat joins Exco InTouch to lead its mHealth strategy

Brincat was the pharma company's former European healthcare informatics director

Mark Brincat has been appointed product development director at Exco InTouch, a Nottingham, UK-based firm that provides interactive mobile patient communication tools for clinical trials.

He joins the company from Pfizer where he where he spent the last thirteen years managing the delivery of emerging and innovative business technology at Pfizer.

Most recently Brincat served as the pharma company's European healthcare informatics director, working across clinical trials, drug compliance, disease management and 'wellness'.

He also managed the first ever remote patient clinical trial, working with Exco and its mobile diary technology.

In his new role at Exco InTouch Brincat will lead mHealth and mobile product strategy with a particular focus on developing targeted tools for specific therapy areas.

He said: "We all know that healthcare is at a crossroads, so there is no better time to be working with pharmaceutical and healthcare providers to deliver effective and innovative new mHealth solutions directly to patients.”

30th January 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....